| Dr Melhem Dandan, MD | |
|
354 E Southcross Blvd Ste 100, San Antonio, TX 78214-3595 | |
| (210) 333-4700 | |
| Not Available |
| Full Name | Dr Melhem Dandan |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 31 Years |
| Location | 354 E Southcross Blvd Ste 100, San Antonio, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053393520 | NPI | - | NPPES |
| 114404 | Other | CA | BOARD CERT # |
| 00A782130 | Other | CA | BLUE SHIELD OF CA PIN |
| 00A782130 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | P0716 (Texas) | Secondary |
| 207Q00000X | Family Medicine | A78213 (California) | Secondary |
| 207Q00000X | Family Medicine | A78213 (Texas) | Primary |
| Entity Name | Christus Trinity Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285684225 PECOS PAC ID: 3072426741 Enrollment ID: O20031204001091 |
News Archive
NPS Pharmaceuticals, Inc. today announced the closing of a public offering of 10,350,000 shares of its common stock, including 1,350,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters. All of the shares were offered by the Company. Net proceeds were approximately $53.3 million after deducting underwriting discounts and commissions, and estimated offering expenses. Canaccord Adams acted as sole book-running manager and Needham & Company, LLC acted as co-manager for the offering.
Corvidia Therapeutics, a biotechnology company focused on the development of precision cardiovascular therapies, announced today that it has raised $26 million in a Series A financing, co-led by seed-investor Sofinnova Partners, and Apple Tree Partners.
Memories of past events and experiences are what define us as who we are, and yet the ability to form these episodic memories declines with age, certain dementias, and brain injury.
A team of researchers led by an epidemiologist at Mount Sinai School of Medicine and University of Iceland has found a correlation between the age at which children with attention-deficit/hyperactivity disorder (ADHD) begin taking medication, and how well they perform on standardized tests, particularly in math.
› Verified 8 days ago
| Entity Name | Bhs Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598958431 PECOS PAC ID: 7315019593 Enrollment ID: O20080703000069 |
News Archive
NPS Pharmaceuticals, Inc. today announced the closing of a public offering of 10,350,000 shares of its common stock, including 1,350,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters. All of the shares were offered by the Company. Net proceeds were approximately $53.3 million after deducting underwriting discounts and commissions, and estimated offering expenses. Canaccord Adams acted as sole book-running manager and Needham & Company, LLC acted as co-manager for the offering.
Corvidia Therapeutics, a biotechnology company focused on the development of precision cardiovascular therapies, announced today that it has raised $26 million in a Series A financing, co-led by seed-investor Sofinnova Partners, and Apple Tree Partners.
Memories of past events and experiences are what define us as who we are, and yet the ability to form these episodic memories declines with age, certain dementias, and brain injury.
A team of researchers led by an epidemiologist at Mount Sinai School of Medicine and University of Iceland has found a correlation between the age at which children with attention-deficit/hyperactivity disorder (ADHD) begin taking medication, and how well they perform on standardized tests, particularly in math.
› Verified 8 days ago
| Entity Name | Dandan Primary Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235804964 PECOS PAC ID: 5193114288 Enrollment ID: O20211110003010 |
News Archive
NPS Pharmaceuticals, Inc. today announced the closing of a public offering of 10,350,000 shares of its common stock, including 1,350,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters. All of the shares were offered by the Company. Net proceeds were approximately $53.3 million after deducting underwriting discounts and commissions, and estimated offering expenses. Canaccord Adams acted as sole book-running manager and Needham & Company, LLC acted as co-manager for the offering.
Corvidia Therapeutics, a biotechnology company focused on the development of precision cardiovascular therapies, announced today that it has raised $26 million in a Series A financing, co-led by seed-investor Sofinnova Partners, and Apple Tree Partners.
Memories of past events and experiences are what define us as who we are, and yet the ability to form these episodic memories declines with age, certain dementias, and brain injury.
A team of researchers led by an epidemiologist at Mount Sinai School of Medicine and University of Iceland has found a correlation between the age at which children with attention-deficit/hyperactivity disorder (ADHD) begin taking medication, and how well they perform on standardized tests, particularly in math.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melhem Dandan, MD 354 E Southcross Blvd Ste 100, San Antonio, TX 78214-3595 Ph: (661) 912-7458 | Dr Melhem Dandan, MD 354 E Southcross Blvd Ste 100, San Antonio, TX 78214-3595 Ph: (210) 333-4700 |
News Archive
NPS Pharmaceuticals, Inc. today announced the closing of a public offering of 10,350,000 shares of its common stock, including 1,350,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters. All of the shares were offered by the Company. Net proceeds were approximately $53.3 million after deducting underwriting discounts and commissions, and estimated offering expenses. Canaccord Adams acted as sole book-running manager and Needham & Company, LLC acted as co-manager for the offering.
Corvidia Therapeutics, a biotechnology company focused on the development of precision cardiovascular therapies, announced today that it has raised $26 million in a Series A financing, co-led by seed-investor Sofinnova Partners, and Apple Tree Partners.
Memories of past events and experiences are what define us as who we are, and yet the ability to form these episodic memories declines with age, certain dementias, and brain injury.
A team of researchers led by an epidemiologist at Mount Sinai School of Medicine and University of Iceland has found a correlation between the age at which children with attention-deficit/hyperactivity disorder (ADHD) begin taking medication, and how well they perform on standardized tests, particularly in math.
› Verified 8 days ago
Dr. Obinna C. Uzowulu, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 22250 Bulverde Rd, Suite 111, San Antonio, TX 78261 Phone: 210-899-4490 Fax: 210-592-8195 | |
Dr. Salima Jaffer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 22800 Bulverde Rd Apt 2202, San Antonio, TX 78261 Phone: 210-878-4033 | |
David A. Ramos, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3110 Nogalitos, Suite 105, San Antonio, TX 78225 Phone: 210-533-0257 Fax: 210-534-0890 | |
Patricia May B. Lacsina, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 903 W Martin St, San Antonio, TX 78207 Phone: 210-358-3441 Fax: 210-358-5944 | |
Adriana S Sanchez, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8300 Floyd Curl Dr, San Antonio, TX 78229 Phone: 210-450-9000 | |
Dr. Aneela N. Hussain, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 4610 E Southcross Blvd, San Antonio, TX 78222 Phone: 210-648-1491 | |
Javier C Bocanegra, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1616 Callaghan Rd, San Antonio, TX 78228 Phone: 210-435-1218 Fax: 210-435-3162 |